14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations

NCT00813306 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Reflux Episodes

Interventions

DRUG: AZD2066
DRUG: Placebo
DRUG: AZD2066
DRUG: AZD2066
DRUG: Placebo

Sponsor

AstraZeneca